218 related articles for article (PubMed ID: 35842705)
1. A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients.
Soltani-Zangbar MS; Parhizkar F; Ghaedi E; Tarbiat A; Motavalli R; Alizadegan A; Aghebati-Maleki L; Rostamzadeh D; Yousefzadeh Y; Jadideslam G; Farid SS; Roshangar L; Mahmoodpoor A; Heris JA; Miahipour A; Yousefi M
Cell Commun Signal; 2022 Jul; 20(1):106. PubMed ID: 35842705
[TBL] [Abstract][Full Text] [Related]
2. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
[TBL] [Abstract][Full Text] [Related]
3. A systematic meta-analysis of immune signatures in patients with COVID-19.
Liu K; Yang T; Peng XF; Lv SM; Ye XL; Zhao TS; Li JC; Shao ZJ; Lu QB; Li JY; Liu W
Rev Med Virol; 2021 Jul; 31(4):e2195. PubMed ID: 34260780
[TBL] [Abstract][Full Text] [Related]
4. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
Hasichaolu ; Zhang X; Li X; Li X; Li D
Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
[TBL] [Abstract][Full Text] [Related]
5. Elevated Exhaustion Levels of NK and CD8
Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
Front Immunol; 2020; 11():580237. PubMed ID: 33154753
[TBL] [Abstract][Full Text] [Related]
6. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
d'Ettorre G; Recchia G; Ridolfi M; Siccardi G; Pinacchio C; Innocenti GP; Santinelli L; Frasca F; Bitossi C; Ceccarelli G; Borrazzo C; Antonelli G; Scagnolari C; Mastroianni CM
Medicine (Baltimore); 2020 Sep; 99(36):e21803. PubMed ID: 32899009
[TBL] [Abstract][Full Text] [Related]
7. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
8. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
9. Immune modulation as a consequence of SARS-CoV-2 infection.
Gelmez MY; Oktelik FB; Tahrali I; Yilmaz V; Kucuksezer UC; Akdeniz N; Cetin EA; Kose M; Cinar C; Oguz FS; Besisik S; Koksalan K; Ozdemir O; Senkal N; Gul A; Tuzun E; Deniz G
Front Immunol; 2022; 13():954391. PubMed ID: 36110850
[TBL] [Abstract][Full Text] [Related]
10. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
[TBL] [Abstract][Full Text] [Related]
11. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.
Romano A; Parrinello NL; Barchitta M; Manuele R; Puglisi F; Maugeri A; Barbato A; Triolo AM; Giallongo C; Tibullo D; La Ferla L; Botta C; Siragusa S; Iacobello C; Montineri A; Volti GL; Agodi A; Palumbo GA; Di Raimondo F
Sci Rep; 2022 May; 12(1):7237. PubMed ID: 35508575
[TBL] [Abstract][Full Text] [Related]
12. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
13. Is IFN expression by NK cells a hallmark of severe COVID-19?
Csordas BG; de Sousa Palmeira PH; Peixoto RF; Comberlang FCQDDS; de Medeiros IA; Azevedo FLAA; Veras RC; Janebro DI; Amaral IPG; Barbosa-Filho JM; Keesen TSL
Cytokine; 2022 Sep; 157():155971. PubMed ID: 35908408
[TBL] [Abstract][Full Text] [Related]
14.
Viurcos-Sanabria R; Manjarrez-Reyna AN; Solleiro-Villavicencio H; Rizo-Téllez SA; Méndez-García LA; Viurcos-Sanabria V; González-Sanabria J; Arroyo-Valerio A; Carrillo-Ruíz JD; González-Chávez A; León-Pedroza JI; Flores-Mejía R; Rodríguez-Cortés O; Escobedo G
Front Immunol; 2022; 13():897995. PubMed ID: 35860236
[TBL] [Abstract][Full Text] [Related]
15. Type I and III interferons are good markers to monitor COVID-19 pathophysiology.
Darif D; Ejghal R; Desterke C; Outlioua A; Hammi I; Lemrani M; Hilali F; Guessous F; Zaid Y; Akarid K
Cytokine; 2023 May; 165():156172. PubMed ID: 36924609
[TBL] [Abstract][Full Text] [Related]
16. [Changes of immune function in patients with 2009 influenza A (H1N1)].
Li CR; Yang J; Jia SL; Wang GB; He YX; Zu Y; Yang WG; Fu D
Zhonghua Er Ke Za Zhi; 2010 Dec; 48(12):947-53. PubMed ID: 21215192
[TBL] [Abstract][Full Text] [Related]
17. The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity.
Chen PK; Yeo KJ; Chang SH; Liao TL; Chou CH; Lan JL; Chang CK; Chen DY
Virol J; 2023 Feb; 20(1):33. PubMed ID: 36810114
[TBL] [Abstract][Full Text] [Related]
18. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
[TBL] [Abstract][Full Text] [Related]
19. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.
de Prost N; Bastard P; Arrestier R; Fourati S; Mahévas M; Burrel S; Dorgham K; Gorochov G; Tandjaoui-Lambiotte Y; Azzaoui I; Fernandes I; Combes A; Casanova JL; Mekontso-Dessap A; Luyt CE
J Clin Immunol; 2021 Apr; 41(3):536-544. PubMed ID: 33616813
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis.
Wang X; Tang Q; Li H; Jiang H; Xu J; Bergquist R; Qin Z
Int J Infect Dis; 2023 May; 130():147-152. PubMed ID: 36907547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
